1. Bristol-Myers gets breakthrough status for Opdivo-Yervoy combo in liver cancer — Roche SMA trial of risdiplam hits target— AbbVie submits sNDA for Imbruvica/Rituximab combo for CLL — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Russ Cason

Discussion in 'Galderma' started by anonymous, Mar 23, 2018 at 11:45 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    he still work with you guys? I need a great rep for SC and I remember that guy could get it done.
     
  2. anonymous

    anonymous Guest

    He left Galderma. You should try LinkedIn.